CD4 and neoplasm: CTLA4 inhibition in tumor-bearing mice resulted in the expansion of effector Th1-like CD4+ T cell subsets similar to the archetypes observed in CTLA4-deficient mice16, suggesting that reducing the constrains imposed by CTLA4 on the differentiation state of CD4+ T cells may contribute to the therapeutic effects of CTLA4 therapy.